US5674286A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bioabsorbable medical implants
Assignee: United States Surgical Corp
•
Filing: 1992-07-15
•
Granted: 1997-10-07
•
Expires: 2012-07-15
Abstract
Abstract A completely bioabsorbable reinforced composite material for use in medical implants and a method for making same. The composite material comprises a hybrid yarn of intimately co-mingled reinforcement fibers of a crystalline polymer and matrix fibers of a polymer having a glass transition temperature below the melting point of the crystalline polymer. The hybrid yarn is heated under pressure to a processing temperature between the glass transition temperature of the matrix fibers and the melting point of the crystalline polymer to form a continuous matrix with reinforcing fibers of crystalline polymer. The composite material may be formed by a two step consolidation process.
Inventors
- 👤 Keith D'Alessio
- 👤 Donald S. Kaplan
- 👤 Ross R. Muth
- 👤 John Kennedy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:38
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/14; A61L31/148; A61B; A61B17/00; A61B17/56; A61B17/58; A61B17/68; A61B17/80; A61L27/00; A61L27/40; A61L27/44; A61L27/48; A61L27/50; A61L27/58; A61L31/12; A61L31/125; A61L31/129; C; C08; C08L; C08L67/00; C08L67/04; A61B2017/00004; A61F; A61F2/00; A61F2/02; A61F2/30; A61F2/3094; A61F2/30965
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
83 words
A bioabsorbable composite surgical implant comprising a hybrid yarn of plied reinforcing and matrix fibers, the reinforcing fibers being made of a bioabsorbable crystalline polymer characterized by a melting point and the matrix fibers being made of a bioabsorbable polymer characterized by a glass transition temperature below the melting point of the crystalline polymer, said hybrid yarn being heated under pressure to a processing temperature above the glass transition temperature of the matrix fibers and below the melting point of the crystalline polymer.
Claim 2
Dependent Claim
83 words
A bioabsorbable composite surgical implant comprising a hybrid yarn of plied reinforcing and matrix fibers, the reinforcing fibers being made of a bioabsorbable crystalline polymer characterized by a melting point and the matrix fibers being made of a bioabsorbable polymer characterized by a glass transition temperature below the melting point of the crystalline polymer, said hybrid yarn being heated under pressure to a processing temperature above the glass transition temperature of the matrix fibers and below the melting point of the crystalline polymer.
Claim 3
Dependent Claim
48 words
The bioabsorbable composite material of claim 1, wherein reinforcing fiber is spun from a polymer selected from the group consisting of polylactic acid, polyglycolic acid, polydioxanone, polytrimethylene carbonate, poly(ethylene carbonate), poly(iminocarbonates), polycaprolactone, polyhydroxybutyrate, polyalkylene oxalates, polyalkylene succinates, poly(maleic acid), poly(1,3-propylene malonate), poly(ethylene terephthalate), poly(amino acids), and copolymers thereof.
Claim 4
Dependent Claim
18 words
The bioabsorbable composite material of claim 1, wherein said bioabsorbable polymers of said matrix fibers are substantially amorphous.
Claim 5
Dependent Claim
27 words
The bioabsorbable composite material of claim 1, wherein the bioabsorbable polymer of said matrix fibers contain a bioabsorbable component having a melting point below said processing temperature.
Claim 6
Dependent Claim
82 words
The bioabsorbable composite material of claim 4, wherein said component is selected from the group consisting of polycaprolactone, polytrimethylene carbonate, polydioxanone, polyorthoesters, copolymers of caprolactone and at least one comonomer selected from the group consisting of and lactic acid and glycolic acid, copolymers of trimethylene carbonate and at least one comonomer selected from the group consisting of lactic acid and glycolic acid, and copolymers of dioxanone and at least one comonomer selected from the group consisting of lactic acid and glycolic acid.
Claim 7
Dependent Claim
38 words
The bioabsorbable composite material of claim 4, wherein said hybrid yarn is treated to remove at least one compound selected from the group consisting of monomers and impurities before said hybrid yarn is heated to the processing temperature.
Claim 8
Dependent Claim
60 words
The bioabsorbable composite material of claim 6, wherein said treatment to remove at least one compound selected from the group consisting of monomers and impurities comprises heating said hybrid yarn to a temperature from about 75° C. to 120° C. under at least a partial vacuum for a period of time sufficient to remove a substantial amount of the compounds.
Claim 9
Dependent Claim
85 words
A bioabsorbable composite surgical implant comprising a hybrid yarn of plied reinforcing and matrix fibers, the reinforcing fibers being made of a bioabsorbable crystalline polymer characterized by a melting point and the matrix fibers being made of a blend of bioabsorbable polymers characterized by a glass transition temperature below the melting point of the crystalline polymer, said hybrid yarn being heated under pressure to a processing temperature above the glass transition temperature of the matrix fibers and below the melting point of the crystalline polymer.
Claim 10
Dependent Claim
85 words
A bioabsorbable composite surgical implant comprising a hybrid yarn of plied reinforcing and matrix fibers, the reinforcing fibers being made of a bioabsorbable crystalline polymer characterized by a melting point and the matrix fibers being made of a blend of bioabsorbable polymers characterized by a glass transition temperature below the melting point of the crystalline polymer, said hybrid yarn being heated under pressure to a processing temperature above the glass transition temperature of the matrix fibers and below the melting point of the crystalline polymer.
References Cited (Backward Citations)
US2703316A
Cited
GB1034123A
Cited
US3297033A
Cited
US3739773A
Cited
US3867190A
Cited
US3784585A
Cited
US3839297A
Cited
US3902497A
Cited
US4128612A
Cited
US4045418A
Cited
US4057537A
Cited
US4052988A
Cited
US4590027A
Cited
US4201216A
Cited
US4279249A
Cited
EP0011528B1
Cited
US4357193A
Cited
US4263185A
Cited
US4343931A
Cited
US4326522A
Cited
US4496446A
Cited
US4620541A
Cited
FI832405L
Cited
US4429080A
Cited
US4539981A
Cited
US4550449A
Cited
WO1984003035A1
Cited
US4610688A
Cited
US4643734A
Cited
US4539249A
Cited
US4655203A
Cited
US4612923A
Cited
US4655777A
Cited
EP0146398A2
Cited
US4799985A
Cited
US4944974A
Cited
US4646741A
Cited
US4800113A
Cited
US4595713A
Cited
US4604097A
Cited
US4604097B1
Cited
US4743257A
Cited
EP0204931A1
Cited
US4743257C1
Cited
US4976909A
Cited
WO1986007250A1
Cited
US4889119A
Cited
US4741337A
Cited
US4624256A
Cited
GB2181438A
Cited
US5061281A
Cited
US4792336A
Cited
EP0239775A2
Cited
EP0241252A2
Cited
US4781183A
Cited
US4898186A
Cited
US4905680A
Cited
US5084051A
Cited
US4960866A
Cited
US4968317B1
Cited
US4968317A
Cited
US5064439A
Cited
WO1989000431A1
Cited
EP0321176B1
Cited
US5120802A
Cited
US5185408A
Cited
US4916193A
Cited
US5066772A
Cited
US4891263A
Cited
US4920203A
Cited
US4916207A
Cited
US5145945A
Cited
US5152781A
Cited
WO1990000410A1
Cited
WO1990007304A1
Cited
EP0408898A2
Cited
US5080665A
Cited
WO1992022599A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-10-06 | 2001-04-07 | 2001-10-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-10-06 | 2005-04-07 | 2005-10-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-10-06 | 2009-04-07 | 2009-10-07 | $7700.00 | Window Closed / Lapsed |